We are live on ! Find out more
SGCM

Sand Grove Capital Management Portfolio holdings

AUM $444M
1-Year Est. Return 131.11%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+131.11%
3 Year Est. Return
+410.73%
5 Year Est. Return
+1,022.21%
10 Year Est. Return
+24,985.77%
AUM
$256M
AUM Growth
-$86M
Cap. Flow
-$94.9M
Cap. Flow %
-37.05%
Top 10 Hldgs %
84.11%
Holding
28
New
8
Increased
3
Reduced
4
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 22.98%
2 Technology 22.72%
3 Consumer Staples 15.74%
4 Energy 12.29%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBOW
26
DELISTED
SilverBow Resources, Inc.
SBOW
-219,452
Closed -$8.3M
HOLI
27
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-1,426,177
Closed -$30.9M
ETRN
28
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-573,448
Closed -$7.44M

Similar funds

Sand Grove Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sand Grove Capital Management held 28 positions worth $256M, down 25% from $342M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Sand Grove Capital Management withdrew a net $94.9M in Q3 2024, closing 13 positions and reducing 4 holdings. Its most notable exit was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Sand Grove Capital Management opened a new position in Kellanova worth $20.3M.

  • Sand Grove Capital Management's largest Q3 2024 buy was Kellanova: 250,946 shares worth $20.3M.
  • Sand Grove Capital Management added most to Squarespace, Inc. in Q3 2024, an estimated $9.61M increase.
  • Sand Grove Capital Management's biggest Q3 2024 reduction was Albertsons Companies, cutting an estimated $19.7M.
  • Sand Grove Capital Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $37.6M.
  • Sand Grove Capital Management's ten largest holdings make up 84% of its $256M portfolio in Q3 2024.
  • Sand Grove Capital Management opened 8 new positions and closed 13 in Q3 2024.
  • Sand Grove Capital Management's portfolio value fell 25% quarter-over-quarter to $256M.

Based on Sand Grove Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.